Nuzenio

Therapeutics Intellia Therapeutics

Therapeutics Intellia Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:10:52 GMTNTLA Stock Rockets After Hours Before Critical Data For Genetic Disorder Therapy - StocktwitsStocktwits · Sat, 08 Aug 2026 16:17:22 GMTBank of America Securities Remains a Hold on Intellia Therapeutics (NTLA) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:58:00 GMTIntellia Therapeutics (NASDAQ:NTLA) Stock Rating Lowered by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:54:20 GMTNTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late - StocktwitsStocktwits · Fri, 07 Aug 2026 22:50:17 GMTIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:01:00 GMTState Street (NTLA) stake: 9.23M Intellia Therapeutics shares in 13G filing - Stock TitanStock Titan · Fri, 07 Aug 2026 13:55:17 GMTWill Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:40:06 GMT

Timeline

Mon, 10 Aug 2026 11:10:52 GMTIntellia Therapeutics, Inc. (NASDAQ:NTLA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Sat, 08 Aug 2026 16:17:22 GMTNTLA Stock Rockets After Hours Before Critical Data For Genetic Disorder Therapy - Stocktwits
Sat, 08 Aug 2026 10:58:00 GMTBank of America Securities Remains a Hold on Intellia Therapeutics (NTLA) - The Globe and Mail
Sat, 08 Aug 2026 07:54:20 GMTIntellia Therapeutics (NASDAQ:NTLA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 22:50:17 GMTNTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late - Stocktwits
Fri, 07 Aug 2026 20:01:00 GMTIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapeutics Intellia Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.